Recent News

• 03.31.2025 - Talphera Full Year and Fourth Quarter 2024 Financial Results Conference Call
• 03.31.2025 - Talphera Full Year and Fourth Quarter 2024 Financial Results Conference Call
• 03.31.2025 - Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 03.31.2025 - Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 03.31.2025 - Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million
• 03.31.2025 - Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million
• 03.26.2025 - Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
• 03.26.2025 - Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
• 01.14.2025 - Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
• 01.14.2025 - Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Recent Filings

• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.11.2024 - 8-K Current report
• 12.06.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.02.2024 - 144 Report of proposed sale of securities